Literature DB >> 30923175

Long-term mortality and cardiovascular burden for adult survivors of coarctation of the aorta.

Yves d'Udekem1,2,3, Michael A Gatzoulis4,5, Melissa G Y Lee1,2,3, Sonya V Babu-Narayan4,5, Aleksander Kempny4,5, Anselm Uebing4,5, Claudia Montanaro4,5, Darryl F Shore5,6.   

Abstract

OBJECTIVE: To examine the contemporary long-term outcome after coarctation repair.
METHODS: This is a retrospective cohort study of 834 patients aged ≥16 years who underwent coarctation repair under single-centre follow-up. Repair was performed at a median age of 3 years (lower-upper quartile: 1 month to 15 years) by surgery in 83% (690/834) and angioplasty/stenting in 17% (144/834). Survival was compared with an age- and gender matched normal population. Other outcomes included arch reintervention, aortic valve intervention, ascending aortic intervention, and residual/re-coarctation and resting hypertension at latest follow-up.
RESULTS: After a median follow-up of 27 years (lower-upper quartile: 18-36), there were 38 late deaths (5%, 38/834). Overall survival was 99%, 88% and 65% at 30, 50 and 70 years of age, respectively, significantly reduced compared with a matched normal population (standardised mortality ratio: 3.20, log-rank: p<0.001). Thirty per cent (246/834) required ≥1 arch reintervention, 13% (111/834) an aortic valve intervention and 5% (43/834) an ascending aortic intervention. Freedom from aortic valve and ascending aortic intervention was 83% and 92% at 50 years and 53% and 81% at 70 years of age, respectively. Residual/re-coarctation (gradient ≥25 mm Hg or repair site/diaphragm ratio ≤70%) at latest follow-up was present in 60% (282/474) and resting hypertension in 57% (379/661).
CONCLUSIONS: Long-term survival in contemporary adult survivors of coarctation repair is significantly lower than a matched normal population with accelerated decline after the third decade. Nearly 60% of patients eventually develop hypertension, whereas approximately 50% require further invasive cardiovascular treatment by 50 years of age. Our risk-stratifying data may enable personalised follow-up strategies for this common congenital heart condition. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  aortic coarctation; bicuspid aortic valve; congenital heart disease surgery

Mesh:

Year:  2019        PMID: 30923175     DOI: 10.1136/heartjnl-2018-314257

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  12 in total

1.  Cardiac Remodeling and Disease Progression in Patients With Repaired Coarctation of Aorta and Aortic Stenosis.

Authors:  Alexander C Egbe; Jae K Oh; Patricia A Pellikka
Journal:  Circ Cardiovasc Imaging       Date:  2021-12-21       Impact factor: 7.792

2.  Prognostic implications of left heart diastolic dysfunction in adults with coarctation of aorta.

Authors:  Alexander C Egbe; William R Miranda; Jae K Oh; Heidi M Connolly
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2021-10-19       Impact factor: 9.130

3.  Isolating the Effect of Arch Architecture on Aortic Hemodynamics Late After Coarctation Repair: A Computational Study.

Authors:  Vahid Goodarzi Ardakani; Harshinee Goordoyal; Maria Victoria Ordonez; Froso Sophocleous; Stephanie Curtis; Radwa Bedair; Massimo Caputo; Alberto Gambaruto; Giovanni Biglino
Journal:  Front Cardiovasc Med       Date:  2022-06-24

4.  Right Heart Dysfunction in Adults With Coarctation of Aorta: Prevalence and Prognostic Implications.

Authors:  Alexander C Egbe; William R Miranda; C Charles Jain; Heidi M Connolly
Journal:  Circ Cardiovasc Imaging       Date:  2021-12-08       Impact factor: 8.589

5.  Identified plasma proteins related to vascular structure are associated with coarctation of the aorta in children.

Authors:  Siyu Ma; Junqiang Zheng; Yang Xu; Zhaocong Yang; Yu Zhu; Xiaoqi Su; Xuming Mo
Journal:  Ital J Pediatr       Date:  2020-05-19       Impact factor: 2.638

6.  Infectious stentitis after treatment of coarctation of the aorta: a case report.

Authors:  Heleen B van der Zwaan; Gertjan Tj Sieswerda; Gregor J Krings; Michiel Voskuil
Journal:  Eur Heart J Case Rep       Date:  2020-05-03

7.  Paradigm shift in treatment of coarctation of the aorta?

Authors:  V Sojak; M Hazekamp
Journal:  Neth Heart J       Date:  2021-01-11       Impact factor: 2.380

8.  Persistent Hypertension and Left Ventricular Hypertrophy After Repair of Native Coarctation of Aorta in Adults.

Authors:  Alexander C Egbe; William R Miranda; Carole A Warnes; Crystal Bonnichsen; Juan Crestanello; Jason H Anderson; Heidi M Connolly
Journal:  Hypertension       Date:  2021-07-12       Impact factor: 9.897

9.  Troponin T Mutation as a Cause of Left Ventricular Systolic Dysfunction in a Young Patient with Previous Surgical Correction of Aortic Coarctation.

Authors:  Martina Caiazza; Michele Lioncino; Emanuele Monda; Francesco Di Fraia; Federica Verrillo; Roberta Pacileo; Federica Amodio; Marta Rubino; Annapaola Cirillo; Adelaide Fusco; Emanuele Romeo; Alessandra Scatteia; Santo Dellegrottaglie; Paolo Calabrò; Berardo Sarubbi; Anwar Baban; Giulia Frisso; Maria Giovanna Russo; Giuseppe Limongelli
Journal:  Biomolecules       Date:  2021-05-06

10.  Four-Dimensional flow Magnetic Resonance Imaging for Assessment of Pediatric Coarctation of the Aorta.

Authors:  Lajja Desai; Heather Stefek; Haben Berhane; Joshua Robinson; Cynthia Rigsby; Michael Markl
Journal:  J Magn Reson Imaging       Date:  2021-06-26       Impact factor: 5.119

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.